Citrate de Potassium 300 mg 90 Gélules
Food supplement declared in France, declaration No 2019-9-721
Citrate de Potassium 300 mg 90 Gélules (PROZIS) is a food supplement declared in France. Status: earlier declaration, replaced by the 2022 declaration. Main ingredients: Potassium. 1 point in its composition requires a check (prohibited substance, dose or novel food). Its name nevertheless states a dose above the maximum set in France in 2006: see the composition.
- Brand
- PROZIS
- Food business operator placing the product on the market
- Prozis.Com, S.A.
- Status
- Earlier declaration, replaced by the 2022 declaration : Citrate de Potassium 300 mg 90 Gélules
- Form
- Capsule
- Daily dose
- 3 gélules
- Directions for use
- Prendre 3 gélules par jour.
- Intended populations
- Men, Women
- Not recommended (according to the manufacturer)
- Breastfeeding women, Pregnant women, Kidney disease
- Objectives stated by the manufacturer (these are not authorised claims)
- Nervous system
Declaration 214867, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| potassium citrate | Potassium | no limit (insufficient data) | 80 mg |
The product name states 300 mg of potassium per serving, above the maximum dose of 80 mg set by the Order of 9 May 2006, not revised since November 2006. Check the dose and number of servings on the label.
Additives
E551, E470b, E171
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Veuillez consulter un médecin avant d'utiliser ce produit si vous êtes enceintes ou si vous allaitez. Non recommandé pour personnes âgées ou souffrant de maladies rénales. Ne pas dépasser la portion journalière recommandée. Ce produit ne doit pas remplacer une alimentation variée et équilibrée et un mode de vie sain. Maintenir hors de la portée des enfants. Conserver bien fermé dans l'emballage d'origine dans un endroit frais et sec, à l'abri de la lumière directe du soleil.
Regulatory points
- À vérifier
The composition lists additive E171 (titanium dioxide), removed from the list of additives allowed in food, supplements included: since 7 August 2022, a supplement containing it can no longer be placed on the market in the Union.
Source: Regulation (EU) 2022/63: titanium dioxide (E171) removed from the food additives allowed in the EU, règlement (UE) 2022/63.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Citrate de Potassium 300 mg 90 Gélules PROZIS, declared in 2022 : different composition: 1 ingredient(s) added, 1 missing
Brand : PROZIS
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.